AstraZeneca
- Active openings
- 450+
- US-based roles
- 100+
- Remote-friendly
- 0
- Last updated
- 2026-09-15
What AstraZeneca is hiring for
Open positions
450+ active- Senior Director RWEWilmington, DESep 15
- Director, Scientific PublicationsBoston, MASep 15
- Associate Specialist (Animal Sciences & Technologies)Cambridge Kendall SQ, MASep 15
- Pharmaceutical Sales Specialist, Respiratory Specialty Care - Owensboro KYOwensboro, KYSep 15
- Pharmaceutical Sales Specialist - R&I Primary Care-Langhorne, PALanghorne, PASep 15
About AstraZeneca
Claim to unlockMission, culture, and benefits - visible once this page is claimed and verified.
Updates
Enhertu demonstrated a median progression-free survival of 14.3 months as 1st-line therapy in patients with HER2-mutant advanced non-small cell lung cancer in DESTINY-Lung04 Phase III trial
Tagrisso demonstrated unprecedented eight-year landmark survival in early-stage EGFR-mutated lung cancer in ADAURA Phase III trial
Update on SERENA-4 Phase III trial of Etcamah in combination with palbociclib in upfront 1st-line advanced ER-positive breast cancer
Imfinzi plus Imdelltra demonstrated a statistically significant and highly clinically meaningful improvement in overall survival and progression-free survival in 1st-line extensive-stage small cell lung cancer
Tozorakimab demonstrated statistically significant and highly clinically meaningful reduction in COPD exacerbations in OBERON and TITANIA Phase III trials
Etcamah in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer